HIGHLIGHTS
- who: Muhammad Nauman Khan from the National Institute of Cardiovascular Diseases (NICVD), Karachi have published the research work: Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction, in the Journal: (JOURNAL) of 24/05/2022
- what: The aim of this study was to assess the safety and tolerability of Sacubitril/Valsartan in patient with HFrEF in Pakistani population.
- how: A weekly telephonic follow-up was made to assess the patient`s medication adherence level and any adverse events. Collected data were analyzed using SPSS version-21 (IBM Corp . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.